231 related articles for article (PubMed ID: 11331748)
1. Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure.
Harding VB; Jones LR; Lefkowitz RJ; Koch WJ; Rockman HA
Proc Natl Acad Sci U S A; 2001 May; 98(10):5809-14. PubMed ID: 11331748
[TBL] [Abstract][Full Text] [Related]
2. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA
J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620
[TBL] [Abstract][Full Text] [Related]
3. Level of beta-adrenergic receptor kinase 1 inhibition determines degree of cardiac dysfunction after chronic pressure overload-induced heart failure.
Tachibana H; Naga Prasad SV; Lefkowitz RJ; Koch WJ; Rockman HA
Circulation; 2005 Feb; 111(5):591-7. PubMed ID: 15668342
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy.
Eckhart AD; Fentzke RC; Lepore J; Lang R; Lin H; Lefkowitz RJ; Koch WJ; Leiden JM
J Mol Cell Cardiol; 2002 Jun; 34(6):669-77. PubMed ID: 12054854
[TBL] [Abstract][Full Text] [Related]
5. betaARK1 inhibition improves survival in a mouse model of heart failure induced by myocardial infarction.
Suzuki Y; Nakano K; Sugiyama M; Imagawa J
J Cardiovasc Pharmacol; 2004 Sep; 44(3):329-34. PubMed ID: 15475830
[TBL] [Abstract][Full Text] [Related]
6. Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice.
Rockman HA; Chien KR; Choi DJ; Iaccarino G; Hunter JJ; Ross J; Lefkowitz RJ; Koch WJ
Proc Natl Acad Sci U S A; 1998 Jun; 95(12):7000-5. PubMed ID: 9618528
[TBL] [Abstract][Full Text] [Related]
7. Acute ischemic cardiac dysfunction is attenuated via gene transfer of a peptide inhibitor of the beta-adrenergic receptor kinase (betaARK1).
Tevaearai HT; Walton GB; Keys JR; Koch WJ; Eckhart AD
J Gene Med; 2005 Sep; 7(9):1172-7. PubMed ID: 15880449
[TBL] [Abstract][Full Text] [Related]
8. Control of myocardial contractile function by the level of beta-adrenergic receptor kinase 1 in gene-targeted mice.
Rockman HA; Choi DJ; Akhter SA; Jaber M; Giros B; Lefkowitz RJ; Caron MG; Koch WJ
J Biol Chem; 1998 Jul; 273(29):18180-4. PubMed ID: 9660778
[TBL] [Abstract][Full Text] [Related]
9. In vivo inhibition of elevated myocardial beta-adrenergic receptor kinase activity in hybrid transgenic mice restores normal beta-adrenergic signaling and function.
Akhter SA; Eckhart AD; Rockman HA; Shotwell K; Lefkowitz RJ; Koch WJ
Circulation; 1999 Aug; 100(6):648-53. PubMed ID: 10441103
[TBL] [Abstract][Full Text] [Related]
10. Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts.
Williams ML; Hata JA; Schroder J; Rampersaud E; Petrofski J; Jakoi A; Milano CA; Koch WJ
Circulation; 2004 Apr; 109(13):1590-3. PubMed ID: 15051637
[TBL] [Abstract][Full Text] [Related]
11. In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction.
Shah AS; White DC; Emani S; Kypson AP; Lilly RE; Wilson K; Glower DD; Lefkowitz RJ; Koch WJ
Circulation; 2001 Mar; 103(9):1311-6. PubMed ID: 11238278
[TBL] [Abstract][Full Text] [Related]
12. Regulation of myocardial betaARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing alpha1B-adrenergic receptors.
Iaccarino G; Keys JR; Rapacciuolo A; Shotwell KF; Lefkowitz RJ; Rockman HA; Koch WJ
J Am Coll Cardiol; 2001 Aug; 38(2):534-40. PubMed ID: 11499749
[TBL] [Abstract][Full Text] [Related]
13. Effects of two Gbetagamma-binding proteins--N-terminally truncated phosducin and beta-adrenergic receptor kinase C terminus (betaARKct)--in heart failure.
Li Z; Laugwitz KL; Pinkernell K; Pragst I; Baumgartner C; Hoffmann E; Rosport K; Münch G; Moretti A; Humrich J; Lohse MJ; Ungerer M
Gene Ther; 2003 Aug; 10(16):1354-61. PubMed ID: 12883532
[TBL] [Abstract][Full Text] [Related]
14. Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor.
Tevaearai HT; Eckhart AD; Shotwell KF; Wilson K; Koch WJ
Circulation; 2001 Oct; 104(17):2069-74. PubMed ID: 11673348
[TBL] [Abstract][Full Text] [Related]
15. Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure.
Rengo G; Lymperopoulos A; Zincarelli C; Donniacuo M; Soltys S; Rabinowitz JE; Koch WJ
Circulation; 2009 Jan; 119(1):89-98. PubMed ID: 19103992
[TBL] [Abstract][Full Text] [Related]
16. Defective beta-adrenergic receptor signaling precedes the development of dilated cardiomyopathy in transgenic mice with calsequestrin overexpression.
Cho MC; Rapacciuolo A; Koch WJ; Kobayashi Y; Jones LR; Rockman HA
J Biol Chem; 1999 Aug; 274(32):22251-6. PubMed ID: 10428792
[TBL] [Abstract][Full Text] [Related]
17. Expression of a beta-adrenergic receptor kinase inhibitor reverses dysfunction in failing cardiomyocytes.
Eckhart AD; Koch WJ
Mol Ther; 2002 Jan; 5(1):74-9. PubMed ID: 11786048
[TBL] [Abstract][Full Text] [Related]
18. Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction.
White DC; Hata JA; Shah AS; Glower DD; Lefkowitz RJ; Koch WJ
Proc Natl Acad Sci U S A; 2000 May; 97(10):5428-33. PubMed ID: 10779554
[TBL] [Abstract][Full Text] [Related]
19. Donor heart contractile dysfunction following prolonged ex vivo preservation can be prevented by gene-mediated beta-adrenergic signaling modulation.
Tevaearai HT; Walton GB; Eckhart AD; Keys JR; Koch WJ
Eur J Cardiothorac Surg; 2002 Nov; 22(5):733-7. PubMed ID: 12414039
[TBL] [Abstract][Full Text] [Related]
20. Modulation of SR Ca2+ release by the triadin-to-calsequestrin ratio in ventricular myocytes.
Kučerová D; Baba HA; Bokník P; Fabritz L; Heinick A; Mát'uš M; Müller FU; Neumann J; Schmitz W; Kirchhefer U
Am J Physiol Heart Circ Physiol; 2012 May; 302(10):H2008-17. PubMed ID: 22427521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
